相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
Helen Mossop et al.
BRITISH JOURNAL OF CANCER (2022)
Randomised clinical trials in critical care: past, present and future
Anders Granholm et al.
INTENSIVE CARE MEDICINE (2022)
Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials
Laura Flight et al.
MEDICAL DECISION MAKING (2022)
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Charlotte A. Bradbury et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Point estimation for adaptive trial designs I: A methodological review
David S. Robertson et al.
STATISTICS IN MEDICINE (2022)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter
Gareth O. Griffiths et al.
TRIALS (2021)
Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Elizabeth G. Ryan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Introduction to statistical simulations in health research
Anne-Laure Boulesteix et al.
BMJ OPEN (2020)
A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
Laura Flight et al.
VALUE IN HEALTH (2019)
Using Bayesian adaptive designs to improve phase III trials: a respiratory care example
Elizabeth G. Ryan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
When to keep it simple - adaptive designs are not always useful
James M. S. Wason et al.
BMC MEDICINE (2019)
Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
C. H. van Werkhoven et al.
INTENSIVE CARE MEDICINE (2019)
Adaptive designs in clinical trials: why use them, and how to run and report them
Philip Pallmann et al.
BMC MEDICINE (2018)
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte et al.
INTENSIVE CARE MEDICINE (2018)
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock
B. Venkatesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes
Ming Zhou et al.
STATISTICS IN MEDICINE (2018)
Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
Laura E. Bothwell et al.
BMJ OPEN (2018)
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial
Jean-Louis Vincent et al.
CRITICAL CARE MEDICINE (2015)
Outcomes and Statistical Power in Adult Critical Care Randomized Trials
Michael O. Harhay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The utility of Bayesian predictive probabilities for interim monitoring of clinical trials
Benjamin R. Saville et al.
CLINICAL TRIALS (2014)
Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection
Maximo Carreras et al.
STATISTICS IN MEDICINE (2013)
An exact method for analysis following a two-stage phase II cancer clinical trial
Gordana Jovic et al.
STATISTICS IN MEDICINE (2010)
Adaptive Designs for Randomized Trials in Public Health
C. Hendricks Brown et al.
ANNUAL REVIEW OF PUBLIC HEALTH (2009)
Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study
L Sung et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
分享论文
